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The worldwide rapid increase in bacterial resistance to numerous antibiotics requires on-going development of new drugs to enter the 
market. As the development of new antibiotics is lengthy and costly, early monitoring of compound’s toxicity is essential in the 
development of novel agents. Our interest is in a rapid, simple, high throughput screening method to assess cytotoxicity induced by 
potential agents. Some intracellular pathogens, such as Mycobacterium tuberculosis primary site of infection is human alveolar macrophages. 
Thus, evaluation of candidate drugs for macrophage toxicity is crucial. Protocols for high throughput drug toxicity screening of 
macrophages using flow cytometry are lacking in the literature. For this application we modified a preexisting technique, propidium 
iodide (PI) exclusion staining and utilized it for rapid toxicity tests. Samples were prepared in 96 well plates and analyzed by flow 





Drug development is a long and costly process. The attrition-
adjusted cost of research to develop and bring to market a 
prescription drug in the US has skyrocketed to $802 million (1).  
 
Only 1:5000 of the compounds starting the process (starting 
point defined as lead compounds identification) end up being a 
drug distributed to the market (2). The Time frame from 
synthesis to FDA approval of drug and distribution to the public 
varies between 10-15 years. Cutting development and regulatory 
review times by 25% will lower total costs by $129 million (3).  
 
The global spread of bacterial resistance to numerous antibiotics 
requires on going development of new drugs. 
 
Tuberculosis (TB) is the most common infectious disease known 
to mankind. Incidence of TB is 8 million people per year; 
prevalence is 1.86 billion people, with case fatality rate of 23% 
worldwide (4). Treatment induces many side effects and is long 
(6-9 months). As a result-multi drug resistant TB spreads. A 
survey in 72 countries suggested that the multi-drug-resistant 
(MDR) TB problem is more wide spread than previously thought 
and is likely worsening (5). Since the organism that causes TB, M. 
tuberculosis is an intracellular pathogen, and its first target is Pick et al.    
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alveolar macrophages, we tested drug candidates on THP-1 cells, 
which are monocytic cell line that can be differentiated in vitro to 
macrophages for toxicity. THP-1 are widely used for in vitro 
infection of M. tuberculosis and other intracellular pathogen like 
Listeria monocytogenes (6) and Legeionella (7). Protocols for high 
throughput analysis of drug toxicity on THP-1 cells are not well 
established in the literature.  
 
Fluorescence-Activated Cell Sorting (FACS), also known as Flow 
Cytometry is an effective method that measures and separates 
properties of cells in flow. Cells in suspension flow through an 
illuminated cell where they scatter laser beamed light and emit 
fluorescence. The fluorescence data is collected, and analyzed 
according to the cells properties, such as granulation, 
fluorochrome binding, size etc. This method allows detection of 
fluorescent dye staining, which is coupled to cell size and 
granularity determinations. Flow cytometry instruments enable 
numerous samples to be run in batch automation for screening 
various potential drugs and doses with little extra effort.  
 
In this report we present a technique for determining compounds 
toxicity on THP-1 cells. This method allows checking many 
compounds simultaneously, and is therefore useful for screening 
processes. This technique is a modification of the propidium 
iodide exclusion staining for drug toxicity determination: 
Propidium iodine (PI) is a DNA intercalating dye that is excluded 
by cells that have their plasma membrane integrity preserved 
(including live or early apoptotic cells), but it enters and stains 
DNA in cells that have damaged membranes, and these are 
considered dead cells (8).  
 
A new family of Bromo-tyrosine compounds active against Gram 
Positive bacteria including TB and MRSA (9) were examined 
using the FACS technique described below. We describe the 
application for EXEG 1706 which was chosen as a representative 
of 36 initial compounds. We found this method to be a short, 
efficient, and inexpensive way to precisely evaluate toxicity, as 
LD50 values were easily obtained for our compounds of interest. 
  
MATERIALS AND METHODS 
 
Growth of THP-1 cells 
 
Monocytic cell line THP-1 (ATCC 202, Rockville, MA) was 
cultured in RPMI 1640 (Hyclone, Logan, UT) supplemented with 
5% Fetal calf serum (FCS), (Hyclone, Logan, UT), and 2 mM L-
glutamine (StemCell Technologies, Vancouver, BC). Cells were 
seeded at a density of 3 x 105 per well in a 96 well plate, and 
incubated with the desired drug concentration in triplicates, to a 
total of 200 µl, at 37°C in a humidified atmosphere of 5% CO2 
for 24h. We used two negative controls for the tests: 1; THP-1 
cells in drug free culture media. 2; THP-1 cells treated for 24 
hours with the maximum concentration of the drug’s solvent 
used in the experiments (4% methanol). As a positive control for 
a compound with apparent activity, THP-1 cells were treated for 
6 hours with 5% H2O2, and subsequently stained with PI. This 
induced approximately 50% cell death in our experiments (data 
not shown). To confirm that there is a strong correlation 
between positive PI staining and cell death we sorted PI negative 
cells using FACS caliber cytometer and found that 95% of the 




A Beckman Coulter EPICS XL MCL (Beckman Coulter, 
Fullerton, CA, USA) equipped wit h  a n  3 2  s a m p l e  a u t o m a t e d  
carousel was used for acquisition of samples. The FL3 gate was 
sensitive to light at 610-625nm, which was ideal for detecting 
emmisions of PI when bound to DNA, which is excited at 
535nm, and emits at 615nm. EXPO32 ADC (Applied Cytometry 
Systems, V 1.1 build 207) software was used for subsequent 
analysis. Sorting of PI positive cells was performed on a BD 
FACS Vantage SE Turbo sort cell sorter (BD biosciences, 
Mississauga, ON, Canada), for confirmation of cell permeability 
using Trypan blue staining. Other models of flow cytometers 
would be useful for this application provided they have a laser 
capable of exciting PI, and a filter capable of detecting it. 
 
The only staining used was PI, and the control was initially used 
as the background, which were THP-1 cells with no additional 




EXEG 1706, a Bromo-tyrosine derivative with molecular weight 
of 778.33 g/mol dissolved in 95% HPLC grade methanol was 
used (9). 
 
Creation of PI + gate 
 
Untreated fresh THP-1 cells after 2-3 passages were stained with 
PI by the protocol outlined, and used as a negative control for PI 
staining. After 24 hours of incubation of THP-1 cells with the 
compound, a gate was drawn selecting a small portion (usually 5-
7%) of cells staining with FL3 intensities over 101, using a 
histogram of the FL3 channel. This gate was then adjusted using 
the cell death positive control, or a sample treated with the 
highest concentration of drug, which resulted in a histogram 
containing a large secondary peak of PI positive cells around 102. 
The gate was adjusted to include this second peak. Alternatively, 
as an additional positive control, THP-1 cells were treated for 6 
hrs with H2O2 in RPMI. As a negative control-methanol 4% was 
used since it was the maximal concentration of the solvent used 
in the experiment of the tested compound. 
 
Creation of forward (FS) / side scatter (SS) dead 
cells gate 
 
Utilizing the untreated negative control for PI staining as 
outlined above, a large dead cell gate is drawn which is to the top 
and left of the healthy cell population. This gate is then adjusted 
with the positive control for PI staining, to make sure that it 
includes the majority of cells which have shifts in their 
forward/side scatter characteristics. 
 
During analysis of cytotoxicity, it is important to correlate 
changes in forward and side scatter characteristics with positive 
PI staining, since positively stained PI cells should become Pick et al.    
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smaller and more granular. This is achieved by comparing the 
number of dead cells gated via the FS/SS dead cell gate with the 
number of PI positive cells. The PI gate is used as the gold 
standard in this analysis, though the FS/SS dead cell gate should 
correlate well with the PI gate, to within ± 10%. 
 
RESULTS AND DISCUSSION 
 
EXEG 1706 was the selected compound to be presented. The 
assay was performed on 7 lead compounds out of 36 initial 
compounds tested. The basis for selecting EXEG 1706 was a 
newly designed family of compounds that were found to be very 
active against TB and MRSA using disc assays and Minimal 
Inhibitory Concentration (MIC) assays. Toxicity tests are usually 
done in animal models, but in order to reduce the cost of drug 
development, preliminary in vitro toxicity assays are required to 
ensure that the least toxic compounds are pursued. 
 
 
Fig. 1: Effect of Compound treatment on THP-1 cell membrane 
permeability as measured by PI exclusion staining. Linear forward scatter vs 
Log side scatter dot plots (A) histograms of PI stain intensity detected on the FL3 
channel (B) of THP-1 cells treated for 24 hours with a lead compound being 
tested for drug toxicity. (I) Healthy THP-1 cells in the log phase of growth, 
treated with drug carrier (4% methanol in culture medium), and stained with PI as 
outlined. 10.9% are dead as determined by the PI gate. This correlates well with 
the indicated dead cell gate based on changes in forward and side scatter. (II) 
THP-1 cells treated with 50 µg/ml of the test compound, 23.7% are PI positive. 
(III) THP-1 cells treated with 100 µg/ml of the test compound, 47.6% are PI 
positive. (IV) THP-1 cells treated with 200 µg/ml of the test compound, 95.3% 
are PI positive = dead cells. 
Figure 1 shows the effect of EXEG 1706 treatment on THP-1 
cell membrane permeability by PI exclusion staining. The toxicity 
effect was measured both by linear forward scatter (X axis) 
v e r s u s  l o g  s i d e  s c a t t e r  ( Y  a x i s ) .  O u r  g a t i n g  i s  b a s e d  o n  t h e  
difference in florescence of target cells-undifferentiated THP-1 
(monocytes) with and without the addition of the tested 
compound at different concentrations. As expected, for the two 
negative controls used, (THP-1 cells in drug free culture media, 
and THP-1 cells treated for 24 hours with 4% methanol-the 
maximum concentration of the drug’s solvent used in the 
experiments) no significant toxicity was observed. As presented 
in Figure 2 the toxicity effect as measured by the death rate of 
THP-1 cells was dose dependent. 
 
 
Fig. 2: Histogram representation of the effect of the EXEG 1706 tested on 
undifferentiated THP-1 cells, as measured by flow cytometry. 
 
This method allowed us to determine the calculated LD50. For 
this compound LD50 is approximately 100 µg/ml. Since the MIC 
of this compound is 2-16 µg/ml (9), we could conclude that the 
drug is relatively not toxic to the monocytic cell line tested. 
Assessment of different LD50 to THP-1 cells from various 
compounds provide a determination of the tested compounds 
safe zone, (the non-harmful dose). This technique allows us to 
compare the toxicity within different compounds of the same 
family, a valuable tool for high throughout screening of various 
drugs from a combinatorial chemistry effort. We used 
actinomycin D as an external reference to validate our method. 
As seen in Figure 3, the toxicity effect is linear between the range 
of 1ng and 10ug /ml. The established LD50 for actinomycin D in 
THP-1 is about 120 ng/ml and is comparable to that described in 
the literature for various cell lines. 
 
PI staining and subsequent FACs analysis is used for different 
applications, however a clear protocol for high throughout 
toxicity could not be found in the literature. Our use of THP-1 
samples prepared in round bottomed 96 well plates allow 
quantitative analysis of toxicity, and minimize the amount of 
cells, drug and staining reagents required for toxicity assessment. 
The use of a flow cytometer with the ability to read directly from Pick et al.    
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Fig. 3: The effect of actinomycin D on undifferentiated THP-1 cells, as 
measured by flow cytometry. 
 
The observed shift in SSC that resulted from our drug treatment 
would indicate an increase in cellular granularity, consistent with 
apoptosis being the route of cell death induced by EXEG 1706. 
Further investigation using more specific methods such as 
Annexin V and 7AAD staining would be required to specify the 
mechanism of cell death (10). 7AAD is comparable to PI staining 
in detecting membrane permeability: It is used for the exclusion 
of nonviable cells as well (11). Annexin V staining is capable of 
detecting apoptosis, thus revealing the type of cell death induced 
by the compound of interest. The combination of Annexin V 
and PI has been used to discriminate early apoptotic cells from 
late apoptotic and necrotic ones, based on the translocation of 
phosphatidyl serine from the inner to the outer layer of the 
plasma membrane of early apoptotic cells stained by annexin V. 
(10, 12-15). While this alternative method would provide a more 
mechanistic explanation of toxicity, this technique is significantly 
more expensive due to reagent cost: $2.50/sample (if the 
reagents are prepared and standardized by you). Common kits 
can cost as much as $4.28/sample, which is extremely expensive 
compared to $0.05/sample with the PI method as outlined. 
Therefore, we suggest that the mechanism of cellular toxicity of a 
given compound is not required at the preliminary stage of high-
throughput screening, and is better left to later studies of the few 
promising agents identified during the screening process.  
 
As previously mentioned, we screened 36 initial compounds for 
disc sensitivity and MIC, Only the most promising seven 
compounds were chosen for further testing with the discussed 
assay. Different compounds within the same family showed 
different toxicity range on the same THP-1 cells (data not 
shown). We have determined that the toxicity of each compound 
is dose dependent; however, we cannot conclude that this pattern 
of toxicity would be the same in other compounds, and this 
needs to be checked individually for each tested compound. 
CONCLUSIONS 
 
This data and protocol indicate that PI exclusion staining in a 96 
well plate, with subsequent flow cytometric analysis is a 
methodology well suited for high-throughput screening. Early 
toxicity assessment of cells in suspension can be determined for 
candidate-drugs treatment using a simple, low cost method that 
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•  FACs buffer: Fresh 3% Fetal calf serum (Gibco, Cat no 16000-044) stored at -20°C, in Phosphate buffer saline (PBS) x1 (pH = 
7.4). 
•  PI Staining buffer: 10mM stock solution in H2O (Stored at 4°C in the dark, since it is light sensitive). 
•  THP-1 monocytic cell line (ATCC 202, Rockville, MA). 
•  Cell culture medium: RPMI (Minimal tissue culture media) 1640 (SIGMA) with the addition of 5% Fetal calf serum + 1% 
Glutamine. 
•  Flat bottom 96 wells Elisa plate (Corning 3595) and U bottom Elisa plate (Falcon 3077 microtest U-bottom). 
•  5% H2O2 for a positive control. 
  
Note: Wear gloves, since Propidium Iodide may be carcinogenic and mutagenic 
 
•  Suspend 3 x 105/well THP-1 human monocytes in 50-100 µl tissue culture medium RPMI) in a flat bottom Elisa plate (Corning 
3595). To minimize well to well cross-contamination during staining, space filled wells so that each will be surrounded by empty 
wells on all sides. 
•  Add compound to be tested at the desired concentrations, to reach a final volume of 200 µl per well. 
•  Incubate the filled plate, covered, for 24 hours at 37°C in 5% CO2. 
•  Resuspend the cells by pipeting up and down 2 times, then transfer the content of each well to a 96 wells U-shaped bottom plate 
(Falcon 353077 microtest U-bottom).  
•  Centrifuge at 800xg for 1 minute.  
•  Flick liquid sharply from plate to sink.  
•  Add 100 µl of freshly prepared FACs buffer to each well containing the macrophages.  
•  Centrifuge again in 800xg for 1 minute. Repeat the washing and centrifuging twice.  
•  Check for pellet.  
•  Dilute Propidium iodide (PI) 10 mM stock - 1:100 in FACs buffer. 
•  Add 100 µl 0.1 mM Propidium iodide to each well.  
•  Refrigerate at 4°C for 20 minutes to let PI penetrate the dead cells 
•  Centrifuge at 800xg for 1 minute. Flick Sharply 
•  Wash with 100 µl FACs buffer, spin at 800xg for one more minute, and flick. Repeat this step twice.  
•  After flicking the third time-add 200 µl FACs buffer again to each well, and resuspend the cells in this buffer.  
•  Transfer the 200 µl of cells into 5-ml plastic tubes containing 300 µl FACs buffer, previously aliquoted. Cover with silver foil.  
•  Read in Flow cytometry machine – 10,000 events/ sample. Histogram gates were established on the FL3 channel on the basis of 
the cell’s incorporation of PI. Three parameters were evaluated; % positive PI cells and cellular forward/side scatter, which 
represent cell size and granularity, respectively.  
•  Analyze data using dedicated software such as Beckman Coulter supplied software (EXPO 32 ADC V1.2). 